✦ LIBER ✦

Indalpine, a specific 5HT uptake inhibitor, in delusional depression

✍ Scribed by R. Jouvent; C. Rodier

Book ID: 119094468
Publisher: Elsevier Science
Year: 1984
Tongue: English
Weight: 102 KB
Volume: 11
Category: Article
ISSN: 0165-1781
DOI: 10.1016/0165-1781(84)90009-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Platelet 5-HT uptake in delusional and n

Platelet 5-HT uptake in delusional and nondelusional depressions

✍ D. Healy; A. O'Halloran; P.A. Carney; B.E. Leonard 📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 627 KB

The effects of indalpine — A selective i

The effects of indalpine — A selective inhibitor of 5-HT uptake -— On rat paradoxical sleep

✍ Sarah Kafi-De St Hilaire; Helli Merica; Jean-Michel Gaillard 📂 Article 📅 1984 🏛 Elsevier Science 🌐 English ⚖ 399 KB

Pharmacological evidence of a possible t

Pharmacological evidence of a possible tryptaminergic regulation of opiate receptors by using indalpine, a selective 5-HT uptake inhibitor

✍ A. Uzan; Marie Kabouche; J. Rataud; G. Le Fur 📂 Article 📅 1980 🏛 Elsevier Science 🌐 English ⚖ 498 KB

PROPRANOLOL AND FEMOXETINE, A 5-HT UPTAK

PROPRANOLOL AND FEMOXETINE, A 5-HT UPTAKE INHIBITOR, IN MIGRAINE PROPHYLAXIS:

✍ P. Kangasniemi; T. Nyrke; H. Lang; E. Petersen 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 45 KB

Binding of a specific 5-HT uptake inhibi

Binding of a specific 5-HT uptake inhibitor, [3H]norzimelidine, to rat brain homogenates

✍ H. Hall; S. Ross; S.O. Ögren; L. Gawell 📂 Article 📅 1982 🏛 Elsevier Science 🌐 English ⚖ 120 KB

Tissue blood flow and cephalic arteriove

Tissue blood flow and cephalic arteriovenous shunting in cats following administration of indalpine, a selective inhibitor of 5-hydroxytryptamine uptake

✍ Dr. Pramod R. Saxena; Dr. Krishna K. Tangri 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 676 KB

Saxena, P.R., and K.K. Tangri: Tissue blood flow and cephalic arteriovenous shunting in cats following administration of indalpine, a selective inhibitor of 5-hydroxytryptamine uptake. Drug Dev. Res. 3:271-280, 1983. A number of observations indicate that a decrease in plasma 5-hydroxytryptamine (5-